Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques

Brain, Behavior, and Immunity

Volumn 50, Issue , 2015, Pages 288-297

  Lee, Kim M ^a,b   Chiu, Kevin B ^a,c   Didier, Peter J ^a   Baker, Kate C ^a,c,d   MacLean, Andrew G ^a,b,c  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d Tulane University   (United States)

Author keywords

Astrocyte; Behavior; Glia; Naltrexone; Plasticity; Self injury

Indexed keywords

NALTREXONE; TOLL LIKE RECEPTOR 2;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOMUTILATION; BRAIN ATROPHY; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FRONTAL CORTEX; GRAY MATTER; IMMUNE DEFICIENCY; INNATE IMMUNITY; MALE; MENTAL HEALTH; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; WHITE MATTER; ANIMAL; ATROPHY; BRAIN; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SELF-INJURIOUS BEHAVIOR;

ANIMALS; ASTROCYTES; ATROPHY; BRAIN; FEMALE; GRAY MATTER; MACACA MULATTA; MALE; NALTREXONE; SELF-INJURIOUS BEHAVIOR; TOLL-LIKE RECEPTOR 2; WHITE MATTER;

EID: 84937679162     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.07.017     Document Type: Article

References (64)

1. Diagnostic criteria from DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Association, Washington, D.C.
2. Comer S.D., Lac S.T., Curtis L.K., Carroll M.E. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J. Pharmacol. Exp. Ther. 1993, 267:1470-1477.
3. Crews F.T., Zou J., Qin L. Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav. Immun. 2011, 25(Suppl 1):S4-S12.
4. Czeh B., Di Benedetto B. Antidepressants act directly on astrocytes: evidences and functional consequences. Eur. Neuropsychopharmacol. 2013, 23:171-185.
5. Czeh B., Simon M., Schmelting B., Hiemke C., Fuchs E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006, 31:1616-1626.
6. Czeh B., Perez-Cruz C., Fuchs E., Flugge G. Chronic stress-induced cellular changes in the medial prefrontal cortex and their potential clinical implications: does hemisphere location matter?. Behav. Brain Res. 2008, 190:1-13.
7. Dellinger-Ness L.A., Handler L. Self-injurious behavior in human and non-human primates. Clin. Psychol. Rev. 2006, 26:503-514.
8. Fatemi S.H., Laurence J.A., Araghi-Niknam M., Stary J.M., Schulz S.C., Lee S., Gottesman I.I. Glial fibrillary acidic protein is reduced in cerebellum of subjects with major depression, but not schizophrenia. Schizophr. Res. 2004, 69:317-323.
9. Fontenot M.B., Padgett E.E., Dupuy A.M., Lynch C.R., De Petrillo P.B., Higley J.D. The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. Comp. Med. 2005, 55:67-74.
10. Fontenot M.B., Musso M.W., McFatter R.M., Anderson G.M. Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta). J. Am. Assoc. Lab. Anim. Sci. 2009, 48:176-184.
11. Gilmer W.S., McKinney W.T. Early experience and depressive disorders: human and non-human primate studies. J. Affect. Disord. 2003, 75:97-113.
12. Gottlieb D.H., Capitanio J.P., McCowan B. Risk factors for stereotypic behavior and self-biting in rhesus macaques (Macaca mulatta): animal's history, current environment, and personality. Am. J. Primatol. 2013, 75:995-1008.
13. Greeneltch K.M., Haudenschild C.C., Keegan A.D., Shi Y. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-alpha production. Brain Behav. Immun. 2004, 18:476-484.
14. Hercher C., Turecki G., Mechawar N. Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression. J. Psychiatr. Res. 2009, 43:947-961.
15. Herman B.H., Hammock M.K., Arthur-Smith A., Egan J., Chatoor I., Werner A., Zelnik N. Naltrexone decreases self-injurious behavior. Ann. Neurol. 1987, 22:550-552.
16. Hutchinson M.R., Bland S.T., Johnson K.W., Rice K.C., Maier S.F., Watkins L.R. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal 2007, 7:98-111.
17. Hutchinson M.R., Zhang Y., Brown K., Coats B.D., Shridhar M., Sholar P.W., Patel S.J., Crysdale N.Y., Harrison J.A., Maier S.F., Rice K.C., Watkins L.R. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 2008, 28:20-29.
18. Hutchinson M.R., Shavit Y., Grace P.M., Rice K.C., Maier S.F., Watkins L.R. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 2011, 63:772-810.
19. Jacobson C.M., Gould M. The epidemiology and phenomenology of non-suicidal self-injurious behavior among adolescents: a critical review of the literature. Arch. Suicide Res. 2007, 11:129-147.
20. Kempf D.J., Baker K.C., Gilbert M.H., Blanchard J.L., Dean R.L., Deaver D.R., Bohm R.P. Effects of extended-release injectable naltrexone on self-injurious behavior in rhesus macaques (Macaca mulatta). Comp. Med. 2012, 62:209-217.
21. Kerr P.L., Muehlenkamp J.J., Turner J.M. Nonsuicidal self-injury: a review of current research for family medicine and primary care physicians. J. Am. Board Fam. Med. 2010, 23:240-259.
22. Kraemer G.W., Clarke A.S. The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Prog. Neuropsychopharmacol. Biol. Psychiatry 1990, 14(Suppl):S141-168.
23. Langbehn D.R., Pfohl B. Clinical correlates of self-mutilation among psychiatric inpatients. Ann. Clin. Psychiatry 1993, 5:45-51.
24. Lee K.M., Chiu K.B., Sansing H.A., Didier P.J., Ficht T.A., Arenas-Gamboa A.M., Roy C.J., Maclean A.G. Aerosol-induced brucellosis increases TLR-2 expression and increased complexity in the microanatomy of astroglia in rhesus macaques. Front. Cell. Infection Microbiol. 2013, 3:86.
25. Lee K.M., Chiu K.B., Sansing H.A., Inglis F.M., Baker K.C., Maclean A.G. Astrocyte atrophy and immune dysfunction in self-harming macaques. PLoS ONE 2013, 8:e69980.
26. Lee K.M., Chiu K.B., Renner N.A., Sansing H.A., Didier P.J., MacLean A.G. Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS. J. Neurovirol. 2014, 20:474-484.
27. Leonard B.E. The concept of depression as a dysfunction of the immune system. Curr. Immunol. Rev. 2010, 6:205-212.
28. Li X., Xu F., Xie L., Ji Y., Cheng K., Zhou Q., Wang T., Shively C., Wu Q., Gong W., Fang L., Zhan Q., Melgiri N.D., Xie P. Depression-like behavioral phenotypes by social and social plus visual isolation in the adult female Macaca fascicularis. PLoS ONE 2013, 8:e73293.
29. Lutz C., Well A., Novak M. Stereotypic and self-injurious behavior in rhesus macaques: a survey and retrospective analysis of environment and early experience. Am. J. Primatol. 2003, 60:1-15.
30. Maezawa I., Swanberg S., Harvey D., LaSalle J.M., Jin L.W. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci. 2009, 29:5051-5061.
31. Marinus L.M., Chase W.K., Novak M.A. Self-biting behavior in rhesus macaques (Macaca mulatta) is preferentially directed to body areas associated with acupuncture analgesia. Am. J. Primatol. 2000, 51:61-74.
32. Mitsuo K., Schwartz J.P. Chronic treatment of newborn rats with naltrexone alters astrocyte production of nerve growth factor. J. Mol. Neurosci. 1993, 4:21-28.
33. Modesto-Lowe V., Van Kirk J. Clinical uses of naltrexone: a review of the evidence. Exp. Clin. Psychopharmacol. 2002, 10:213-227.
34. Mueller K., Nyhan W.L. Pharmacologic control of pemoline induced self-injurious behavior in rats. Pharmacol. Biochem. Behav. 1982, 16:957-963.
35. Nagamitsu S. CSF beta-endorphin levels in pediatric neurologic disorders. Kurume Med. J. 1993, 40:233-241.
36. Norton P.J., Temple S.R., Pettit J.W. Suicidal ideation and anxiety disorders: elevated risk or artifact of comorbid depression?. J. Behav. Ther. Exp. Psychiatry 2008, 39:515-525.
37. Novak M.A. Self-injurious behavior in rhesus monkeys: new insights into its etiology, physiology, and treatment. Am. J. Primatol. 2003, 59:3-19.
38. Oberheim N.A., Goldman S.A., Nedergaard M. Heterogeneity of astrocytic form and function. Methods Mol. Biol. 2012, 814:23-45.
39. Phulwani N.K., Esen N., Syed M.M., Kielian T. TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J. Immunol. 2008, 181:3841-3849.
40. Renner N.A., Redmann R.K., Moroney-Rasmussen T., Sansing H.A., Aye P.P., Didier P.J., Lackner A.A., Maclean A.G. S100beta as a novel and accessible indicator for the presence of monocyte-driven encephalitis in AIDS. Neuropathol. Appl. Neurobiol. 2012, 38:162-174.
41. Renner N.A., Sansing H.A., Inglis F.M., Mehra S., Kaushal D., Lackner A.A., Maclean A.G. Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes. J. Cell. Physiol. 2013, 228:1284-1294.
42. Ribka E.P., Baker K.C. Naltrexone (naltrexone hydrochloride) as a treatment to decrease incidence and severity of self-injurious behavior in rhesus macaques (Macaca mulatta). Am. J. Primatol. 2004, 62:31-47.
43. Rommeck I., Anderson K., Heagerty A., Cameron A., McCowan B. Risk factors and remediation of self-injurious and self-abuse behavior in rhesus macaques. J. Appl. Anim. Welf. Sci. 2009, 12:61-72.
44. Rowlett J.K., Wilcox K.M., Woolverton W.L. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J. Pharmacol. Exp. Ther. 1998, 286:61-69.
45. Roy A., Roy M., Deb S., Unwin G., Roy A. Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review. J. Intellect. Disabil. Res. 2014.
46. Sandman C.A., Datta P.C., Barron J., Hoehler F.K., Williams C., Swanson J.M. Naloxone attenuates self-abusive behavior in developmentally disabled clients. Appl. Res. Ment. Retard. 1983, 4:5-11.
47. Sandman C.A., Touchette P.E., Marion S.D., Chicz-DeMet A. The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Dev. Psychobiol. 2008, 50:680-689.
48. Schroeder S.R., Marquis J.G., Reese R.M., Richman D.M., Mayo-Ortega L., Oyama-Ganiko R., LeBlanc J., Brady N., Butler M.G., Johnson T., Lawrence L. Risk factors for self-injury, aggression, and stereotyped behavior among young children at risk for intellectual and developmental disabilities. Am. J. Intellect. Dev. Disabil. 2014, 119:351-370.
49. Snook E.R., Fisher-Perkins J.M., Sansing H.A., Lee K.M., Alvarez X., Maclean A.G., Peterson K.E., Lackner A.A., Bunnell B.A. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy. Am. J. Pathol. 2013.
50. Snook E.R., Fisher-Perkins J.M., Sansing H.A., Lee K.M., Alvarez X., MacLean A.G., Peterson K.E., Lackner A.A., Bunnell B.A. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy. Am. J. Pathol. 2014, 184:382-396.
51. Stanley B., Sher L., Wilson S., Ekman R., Huang Y.Y., Mann J.J. Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J. Affect. Disord. 2010, 124:134-140.
52. Sun J.D., Liu Y., Yuan Y.H., Li J., Chen N.H. Gap junction dysfunction in the prefrontal cortex induces depressive-like behaviors in rats. Neuropsychopharmacology 2012, 37:1305-1320.
53. Symons F.J., Thompson T. Self-injurious behaviour and body site preference. J. Intellect. Disabil. Res. 1997, 41(Pt 6):456-468.
54. Tasker J.G., Oliet S.H., Bains J.S., Brown C.H., Stern J.E. Glial regulation of neuronal function: from synapse to systems physiology. J. Neuroendocrinol. 2012, 24:566-576.
55. Tiefenbacher S., Novak M.A., Marinus L.M., Chase W.K., Miller J.A., Meyer J.S. Altered hypothalamic-pituitary-adrenocortical function in rhesus monkeys (Macaca mulatta) with self-injurious behavior. Psychoneuroendocrinology 2004, 29:501-515.
56. Tiefenbacher S., Novak M.A., Lutz C.K., Meyer J.S. The physiology and neurochemistry of self-injurious behavior: a nonhuman primate model. Front. Biosci. 2005, 10:1-11.
57. Torres-Platas S.G., Hercher C., Davoli M.A., Maussion G., Labonte B., Turecki G., Mechawar N. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacology 2011, 36:2650-2658.
58. Torres-Platas S.G., Nagy C., Wakid M., Turecki G., Mechawar N. Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides. Mol. Psychiatry 2015.
59. Tynan R.J., Beynon S.B., Hinwood M., Johnson S.J., Nilsson M., Woods J.J., Walker F.R. Chronic stress-induced disruption of the astrocyte network is driven by structural atrophy and not loss of astrocytes. Acta Neuropathol. 2013, 126:75-91.
60. Wang H.Y., Frankfurt M., Burns L.H. High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence. PLoS ONE 2008, 3:e1554.
61. Willard S.L., Riddle D.R., Forbes M.E., Shively C.A. Cell number and neuropil alterations in subregions of the anterior hippocampus in a female monkey model of depression. Biol. Psychiatry 2013.
62. Willemsen-Swinkels S.H., Buitelaar J.K., Weijnen F.G., van Engeland H. Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Res. 1995, 58:203-215.
63. Willemsen-Swinkels S.H., Buitelaar J.K., Weijnen F.G., Thijssen J.H., Van Engeland H. Plasma beta-endorphin concentrations in people with learning disability and self-injurious and/or autistic behaviour. Br. J. Psychiatry 1996, 168:105-109.
64. Winchel R.M., Stanley M. Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am. J. Psychiatry 1991, 148:306-317.